Clinical Trial Update: Targeting Spreading Depolarization After Chronic Subdural Hematoma Surgery (TASD) [EARLY_Phase 1]

View source ↗

Summary

The TASD Phase 1 trial targeting spreading depolarization after chronic subdural hematoma surgery has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Snippet

Sponsor: University of New Mexico | Conditions: Chronic Subdural Hematoma | EARLY_Phase 1 | Status: WITHDRAWN